Combined influence of illness duration and medication type on visual sensitivity in schizophrenia

被引:6
|
作者
de Almeida, Natalia L. [1 ]
Fernandes, Thiago P. [1 ]
Lima, Eveline H. [1 ]
Sales, Hemerson F. [1 ]
Santos, Natanael A. [1 ]
机构
[1] Univ Fed Paraiba UFPB, Lab Percepcao Neurociencias & Comportamento LPNeC, Joao Pessoa, Paraiba, Brazil
关键词
Schizophrenia; contrast sensitivity function; illness duration; antipsychotics; psychiatry;
D O I
10.1590/1516-4446-2018-0331
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function. Methods: Data were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings. Results: Patients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years. Conclusion: Visual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
  • [1] Attentional networks in schizophrenia: influence of type of medication and duration of disease
    Rabah, Y.
    Azouz, O. Ben
    Kebir, O.
    Johnson, I.
    Dellagi, L.
    Amado, I.
    Tabbane, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S279 - S279
  • [2] A voxel-based DTI analysis of illness, duration and medication in schizophrenia
    Kanaan, R
    Barker, G
    Chitnis, X
    Shergill, S
    Picchioni, M
    Woolley, J
    Allin, M
    Murray, R
    McGuire, P
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 160 - 160
  • [3] Duration of illness and intelligence in schizophrenia
    Wolitzky, R
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 106 - 106
  • [4] Illness duration and neuropsychological impairments in schizophrenia
    Cuesta, MJ
    Peralta, V
    Zarzuela, A
    SCHIZOPHRENIA RESEARCH, 1998, 33 (03) : 141 - 150
  • [5] Duration of illness and structure of symptoms in schizophrenia
    Mojtabai, R
    PSYCHOLOGICAL MEDICINE, 1999, 29 (04) : 915 - 924
  • [6] AMPHETAMINE RESPONSE AND DURATION OF ILLNESS IN SCHIZOPHRENIA
    ANGRIST, B
    SANFILIPO, M
    WOLKIN, A
    SCHIZOPHRENIA RESEARCH, 1991, 5 (03) : 200 - 201
  • [7] Visual P3 amplitude modulation deficit in schizophrenia is independent of duration of illness
    Neuhaus, Andres H.
    Hahn, Eric
    Hahn, Constanze
    Thi Minh Tam Ta
    Opgen-Rhein, Carolin
    Urbanek, Carsten
    Dettling, Michael
    SCHIZOPHRENIA RESEARCH, 2011, 130 (1-3) : 210 - 215
  • [8] Visual Integration Dysfunction in Schizophrenia Arises by the First Psychotic Episode and Worsens With Illness Duration
    Keane, Brian P.
    Paterno, Danielle
    Kastner, Sabine
    Silverstein, Steven M.
    JOURNAL OF ABNORMAL PSYCHOLOGY, 2016, 125 (04) : 543 - 549
  • [9] No Influence of Age at Onset and Duration of Illness on Executive Functioning Among Patients with Schizophrenia
    Gadelha, Ary
    Berberian, Arthur A.
    Rocha, Deyves M. L. V.
    Scarpato, Bruno S.
    Matsuzaka, Camila T.
    Maranhao, Mara F.
    Noto, Cristiano S.
    Santos Filho, Airton F.
    Smith, Marilia A. C.
    Mari, Jair J.
    Bressan, Rodrigo A.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 83S - 83S
  • [10] PREVIOUS MEDICATION DURATION OF ILLNESS AND PLACEBO RESPONSE
    RICKELS, K
    LIPMAN, R
    RAAB, E
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1966, 142 (06) : 548 - &